These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 27025962)

  • 1. Dissociated sterol-based liver X receptor agonists as therapeutics for chronic inflammatory diseases.
    Yu S; Li S; Henke A; Muse ED; Cheng B; Welzel G; Chatterjee AK; Wang D; Roland J; Glass CK; Tremblay M
    FASEB J; 2016 Jul; 30(7):2570-9. PubMed ID: 27025962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with TO901317, a synthetic liver X receptor agonist, reduces brain damage and attenuates neuroinflammation in experimental intracerebral hemorrhage.
    Wu CH; Chen CC; Lai CY; Hung TH; Lin CC; Chao M; Chen SF
    J Neuroinflammation; 2016 Mar; 13(1):62. PubMed ID: 26968836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of notch enhances the anti-atherosclerotic effects of LXR agonists while reducing fatty liver development in ApoE-deficient mice.
    Hao Y; Wang X; Zhang F; Wang M; Wang Y; Wang H; Du Y; Wang T; Fu F; Gao Z; Zhang L
    Toxicol Appl Pharmacol; 2020 Nov; 406():115211. PubMed ID: 32853627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nuclear receptor corepressor-dependent pathway mediates suppression of cytokine-induced C-reactive protein gene expression by liver X receptor.
    Blaschke F; Takata Y; Caglayan E; Collins A; Tontonoz P; Hsueh WA; Tangirala RK
    Circ Res; 2006 Dec; 99(12):e88-99. PubMed ID: 17110595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the Liver X Receptor Pathway Inhibits HBV Replication in Primary Human Hepatocytes.
    Zeng J; Wu D; Hu H; Young JAT; Yan Z; Gao L
    Hepatology; 2020 Dec; 72(6):1935-1948. PubMed ID: 32145089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological LXR activation reduces presence of SR-B1 in liver membranes contributing to LXR-mediated induction of HDL-cholesterol.
    Grefhorst A; Oosterveer MH; Brufau G; Boesjes M; Kuipers F; Groen AK
    Atherosclerosis; 2012 Jun; 222(2):382-9. PubMed ID: 22481067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. II. LXRs suppress lipid degradation gene promoters through inhibition of PPAR signaling.
    Ide T; Shimano H; Yoshikawa T; Yahagi N; Amemiya-Kudo M; Matsuzaka T; Nakakuki M; Yatoh S; Iizuka Y; Tomita S; Ohashi K; Takahashi A; Sone H; Gotoda T; Osuga J; Ishibashi S; Yamada N
    Mol Endocrinol; 2003 Jul; 17(7):1255-67. PubMed ID: 12730332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of ERK1/2 and activation of LXR synergistically reduce atherosclerotic lesions in ApoE-deficient mice.
    Chen Y; Duan Y; Yang X; Sun L; Liu M; Wang Q; Ma X; Zhang W; Li X; Hu W; Miao RQ; Xiang R; Hajjar DP; Han J
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):948-59. PubMed ID: 25810299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of tissue selective liver X receptor agonists for the treatment of atherosclerosis without causing hepatic lipogenesis.
    Li C; Chen H; Chen X; Li Y; Hua P; Wei J; Song C; Gu Q; Zhou H; Zhang J; Xu J
    Eur J Med Chem; 2019 Nov; 182():111647. PubMed ID: 31499362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ozone-derived Oxysterols Affect Liver X Receptor (LXR) Signaling: A POTENTIAL ROLE FOR LIPID-PROTEIN ADDUCTS.
    Speen AM; Kim HH; Bauer RN; Meyer M; Gowdy KM; Fessler MB; Duncan KE; Liu W; Porter NA; Jaspers I
    J Biol Chem; 2016 Nov; 291(48):25192-25206. PubMed ID: 27703007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of liver X receptor decreases atherosclerosis in Ldlr⁻/⁻ mice in the absence of ATP-binding cassette transporters A1 and G1 in myeloid cells.
    Kappus MS; Murphy AJ; Abramowicz S; Ntonga V; Welch CL; Tall AR; Westerterp M
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):279-84. PubMed ID: 24311381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of Liver X Receptor Has Potent Anti-HIV Effects in a Humanized Mouse Model of HIV Infection.
    Ramezani A; Dubrovsky L; Pushkarsky T; Sviridov D; Karandish S; Raj DS; Fitzgerald ML; Bukrinsky M
    J Pharmacol Exp Ther; 2015 Sep; 354(3):376-83. PubMed ID: 26126533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-inflammatory effects of naturally occurring retinoid X receptor agonists isolated from Sophora tonkinensis Gagnep. via retinoid X receptor/liver X receptor heterodimers.
    Wang W; Nakashima KI; Hirai T; Inoue M
    J Nat Med; 2019 Mar; 73(2):419-430. PubMed ID: 30656541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver X receptor activation inhibits SGLT2-mediated glucose transport in human renal proximal tubular cells.
    Chonlaket P; Wongwan T; Soodvilai S
    Exp Physiol; 2018 Feb; 103(2):250-260. PubMed ID: 29127736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1α-Hydroxy derivatives of 7-dehydrocholesterol are selective liver X receptor modulators.
    Endo-Umeda K; Aoyama A; Shimizu M; Ishikawa M; Hashimoto Y; Yamada S; Makishima M
    J Steroid Biochem Mol Biol; 2017 Sep; 172():136-148. PubMed ID: 28736297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The challenges and promise of targeting the Liver X Receptors for treatment of inflammatory disease.
    Fessler MB
    Pharmacol Ther; 2018 Jan; 181():1-12. PubMed ID: 28720427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. n-3 fatty acids ameliorate hepatic steatosis and dysfunction after LXR agonist ingestion in mice.
    Jung UJ; Millman PN; Tall AR; Deckelbaum RJ
    Biochim Biophys Acta; 2011 Sep; 1811(9):491-7. PubMed ID: 21704188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver X receptor activation inhibits osteoclastogenesis by suppressing NF-κB activity and c-Fos induction and prevents inflammatory bone loss in mice.
    Kim HJ; Yoon KA; Yoon HJ; Hong JM; Lee MJ; Lee IK; Kim SY
    J Leukoc Biol; 2013 Jul; 94(1):99-107. PubMed ID: 23657115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T0901317 is a potent PXR ligand: implications for the biology ascribed to LXR.
    Mitro N; Vargas L; Romeo R; Koder A; Saez E
    FEBS Lett; 2007 May; 581(9):1721-6. PubMed ID: 17418145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stigmasterol stimulates transintestinal cholesterol excretion independent of liver X receptor activation in the small intestine.
    Lifsey HC; Kaur R; Thompson BH; Bennett L; Temel RE; Graf GA
    J Nutr Biochem; 2020 Feb; 76():108263. PubMed ID: 31759199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.